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Abstract The catalytic zinc of astacin, a prototype of the
astacin family and the metzincin superfamily of metalloprotei-
nases is coordinated by three histidines, a glutamate bound water
and a tyrosine. In order to assess the roles of active site key
residues, two mutants, Glu93Ala-astacin and Tyr149Phe-asta-
cin, were expressed in Escherichia coli, affinity-purified and
renatured. While the Glu93Ala mutant was inactive, the
Tyr149Phe mutant retained about 2.5% residual activity toward
Dns-Pro-Lys-Arg*Ala-Pro-Trp-Val, based on the kcat/Km value
for recombinant wild-type astacin. These results support a model
in which Glu93 is the general base in substrate hydrolysis,
whereas Tyr149 contributes to transition state binding. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The collagenolytic zinc endopeptidase astacin of the cray-
¢sh Astacus astacus L. is the prototype of the astacin family
[1^3] and the metzincin superfamily [4,5]. The physiological
roles of these proteases, which include the BMP1/Tolloid-like
enzymes [6^9], hatching proteases [10,11] and the meprins [12^
14], are ranging from food digestion to functions during em-
bryonic development and tissue di¡erentiation.
The catalytic zinc ion in the active center of astacin is co-
ordinated by three histidine residues (His92, His96 and
His102), one glutamic acid (Glu93) bridged water molecule
and a tyrosine residue (Tyr149; Fig. 1) [15]. While the histi-
dine ligands and the glutamic acid residue are part of the zinc
binding consensus sequence HExxHxxGxxH, the tyrosine li-
gand is located in a conserved motif, the Met-turn, containing
an invariant methionine residue (Met147; Fig. 1) [4]. Beside
the extended zinc binding motif, this Met-turn is a key feature
of metzincin-type peptidases, namely the adamalysins/reproly-
sins/ADAMs (ADAM = A Disintegrin And Metalloprotei-
nase), the matrixins and the serralysins. Among these, only
the serralysins and the astacins contain a tyrosine residue as a
¢fth zinc ligand [4].
When the three-dimensional structure of astacin was eluci-
dated [15], the observation of this ¢fth metal ligand raised the
question about its function, since the coordination sphere of
the zinc ion seemed to be overcrowded by ¢ve ligands already
in the absence of a substrate [2]. Hence, it was proposed that a
rearrangement of Tyr149 should be necessary for substrate
binding and catalysis [2]. This assumption was con¢rmed by
X-ray crystal structure analysis of astacin complexed with a
transition state analogue inhibitor [16]. In this complex the
critical Tyr149 had moved by rotation around its backbone
into a position 0.5 nm (5 Aî ) removed from the zinc ion which
was now coordinated by the inhibitor’s phosphinyl group
mimicking the tetracoordinated carbon during substrate turn-
over. The tyrosyl hydroxyl being in hydrogen bonding dis-
tance to one of the phosphinyl oxygens. This scenario of a
‘tyrosine switch’ during substrate binding suggested a role for
this tyrosine residue in transition state stabilization [16], which
appeared in accordance with earlier observations on the neu-
tral peptidases thermolysin and carboxypeptidase A [17^19].
There His231 (thermolysin) [18] and Arg127 (carboxypepti-
dase A) [17,19] form hydrogen bonds to transition state ana-
logue phosphonyl oxygens and can be considered as counter-
parts of Tyr149 in astacin. However, in contrast to Tyr149
(Ast), His231 (TL) and Arg127 (CPA) are not involved in zinc
coordination. Replacement of His231 in a thermolysin-like
Bacillus neutral protease results in a mutant with reduced
activity [20], supporting the function of this residue in tran-
sition state stabilization during catalysis.
The active sites of astacin and the thermolysin-like enzymes
are topologically similar [4,5]. They have in common the short
zinc binding sequence HExxH, but in contrast to the penta-
coordinated zinc ion of the astacins, the metal in these neutral
peptidases is tetrahedrally coordinated by only four ligands
including one glutamic acid residue (Glu166, His142, His146
and one water molecule), hence the designation gluzincins
[21]. In thermolysin, Glu143 (corresponding to Glu93 of as-
tacin) included in the HExxH motif is thought to act as the
general base during catalysis, which transfers a proton from
the catalytic water to the amide of the scissile peptide bond.
However, an alternative mechanism has been discussed re-
cently for thermolysin-like metallopeptidases [22] and for ser-
ralysins [23], attributing the role of the general base to His231
in thermolysin and Tyr216 in serralysin, respectively. Muta-
genesis studies on astacin or serralysin, which could shed light
on the role of the critical glutamate and tyrosine residues in
their active sites, have been lacking so far.
In order to clarify the role of the tyrosine residue in astacin-
like enzymes, we used site-directed mutagenesis to substitute
active site key residues by non-functional ones. The mutants
Tyr149Phe-astacin and Glu93Ala-astacin were expressed in
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Escherichia coli cells, puri¢ed and renatured. We show that
the Glu93Ala mutant is catalytically inactive and the Tyr149-
Phe mutant is 40-fold less active than the wild-type en-
zyme.
2. Materials and methods
2.1. Site-directed mutagenesis
Site speci¢c mutagenesis of the recombinant wild-type astacin [24]
was performed using the ‘ExSite1 PCR-based site-directed mutagen-
esis kit’ (Stratagene, Heidelberg, Germany). The mutations were in-
troduced with the 5P-phosphorylated (Ph) primers (TIB MOLBIOL,
Berlin, Germany): Tyr149Phe-sense 5P-Ph-ATGCACTTCGGCAAG-
TACTCCTTCTCCATACAG; Tyr149Phe-antisense 5P-Ph-TATG-
CTGTAGT ACTGGTAATCCT CACCCACATAGCG; Glu93Ala-
sense 5P-Ph- GCGCTCATGCATGCCATTGGCTTC; Glu93Ala-anti-
sense 5P-Ph-ATGGATGATGGTGCCATGGTAAACACAACC.
The sense primers were carrying the respective changed triplet
(underlined). Sense and antisense primers bind to their cognate
cDNA strands, thereby not overlapping, but bordering on each other.
The following ampli¢cation of the whole plasmid was performed in
a thermocycler (Hybaid, Middlesex, UK) using one cycle (i) 94‡C
(4 min), 52‡C (2 min), 72‡C (2 min), 12 cycles (ii) 94‡C (1 min),
58‡C (2 min), 72‡C (1 min); and one cycle (iii) 72‡C (5 min).
Epicurian Coli0 XL1-Blue supercompetent cells (included in the
kit) were transformed with the resulting circular plasmids pET3a-
Y149F-astacin and pET3a-E93A-astacin. Both sequences were con-
¢rmed by DNA sequencing (SeqLab, Go«ttingen, Germany).
2.2. Protein expression
The recombinant astacins were expressed for 4 h by E. coli
BL21(DE3) cells grown at 37‡C to an optical density of 0.7^0.9 at
600 nm, after induction with 0.4 mM IPTG (isopropyl L-D-thiogalac-
topyranoside) as described [24]. The overexpressed protein is depos-
ited in the form of inclusion bodies in the cytoplasm.
2.3. Protein puri¢cation and renaturation
2.3.1. Nickel nitrilotriacetic acid (Ni-NTA) a⁄nity chromato-
graphy. 3.5 g bacteria cell pellet was mixed with 50 Wl L-mercapto-
ethanol for 3 min before adding 5U1 ml lysis bu¡er (6 M guanidine
hydrochloride (GuHCl), 0.1 M NaH2PO4, 0.01 M Tris^HCl, pH 8.0,
1 WM pepstatin, 2 WM trans-epoxysuccinyl-L-leucylamido-4-guanidino
butane (E64), 500 WM phenylmethylsulfonyl £uoride) and followed by
a 60 min incubation under stirring. Another 30 ml lysis bu¡er was
added and the mixture was further incubated for 30 min. After cen-
trifugation (15 min at 10 000Ug), the supernatant was applied to a
Ni-NTA a⁄nity column (Qiagen, Hilden, Germany). The column was
subsequently washed with 6 M GuHCl, 0.1 M NaH2PO4, 0.01 M
Tris^HCl, pH 8.0. Further washing of the column was performed
with the same bu¡er by stepwise lowering the pH value to 6.3 and
5.9. Final elution was achieved at pH 4.5.
2.3.2. Protein renaturation. Renaturation after Ni-NTA a⁄nity
chromatography was achieved by diluting the protein to a concentra-
tion of 10 Wg/ml into 50 mM Tris^HCl bu¡er pH 8.0, containing 0.8 M
L-arginine, 0.1 mM oxidized glutathione, 1 mM reduced glutathione
[24], and 1 mM Pro-Leu-Gly-NHOH followed by incubation for 24 h
at 4‡C. Finally the protein solution was dialyzed against 50 mM Tris^
HCl bu¡er pH 7.0 in the presence of 10 WM ZnSO4.
2.3.3. Pro-Leu-Gly-NHOH a⁄nity chromatography [25]. Rena-
tured proteins were applied to a Pro-Leu-Gly-hydroxamate a⁄nity
column, equilibrated with 50 mM Tris^HCl bu¡er pH 7.0 [23]. The
column was washed with 0.1 M Tris^HCl pH 8.0, 0.5 M NaCl and
then eluted with 0.1 M Tris bu¡er/0.5 M NaCl. For neutralization of
the high pH value due to the elution bu¡er, the fractions were col-
lected in an equal volume of 0.3 M Tris^HCl bu¡er pH 7.5.
2.4. Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and Western blot analysis
SDS^PAGE was performed according to standard procedures in
14% polyacrylamide gels. In the case of samples containing GuHCl,
a trichloro acetic acid precipitation was performed prior to electro-
phoresis according to the protocol of Qiagen (Hilden, Germany).
Coomassie brilliant blue G250 was used for background free gel stain-
ing [26].
Proteins were blotted onto PVDF (polyvinylidene di£uoride) mem-
branes using a semi-dry blotting apparatus (Phero-Multiblot tMUL-
100, Biotech Fischer). The membranes were blocked by 2 h incubation
with 5% low fat milk powder in TBS bu¡er pH 7.4. Polyclonal rabbit
anti-astacin antiserum, preabsorbed with BL21(DE3)pET3a total cell
extract, was used for immunodetection of the transferred proteins.
The second antibody (goat anti-rabbit, coupled with horseradish per-
oxidase) was added after incubation for 2 h at room temperature and
washing with TBS bu¡er. The ECL Western blot detection kit (Amer-
sham Life Sciences, Braunschweig, Germany) was used for the chem-
iluminescent substrate reaction according to the manufacturer’s man-
ual.
Fig. 1. The active site zinc ion (magenta) of astacin is trigonal bipyramidally coordinated by three histidine residues, a water molecule (red)
and a tyrosine residue [15]. His92, His96, His102 and the water-linked Glu93 are part of the consensus sequence HExxHxxGxxH. Tyr149 is lo-
cated in the conserved Met-turn motif, named after the depicted methionine residue (Met147). Molscript [31] was used for modelling.
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2.5. Gelatin zymography
SDS^PAGE gels containing 0.1% gelatin were used for enzyme
activity assays.
After electrophoresis, the gel was washed 1 h with 2.5% Triton X-
100 followed by 16 h incubation in 0.05 M Tris^HCl pH 7.5/0.2 M
NaCl/0.005 M CaCl2. Uncolored spots localize proteolytic activity on
the Coomassie brilliant blue G250-stained gels.
2.6. Enzyme kinetics
Enzyme activity was determined with a Luminescence Spectrometer
LS 50 (Perkin-Elmer) using the quenched £uorescent substrate 5-(di-
methylamino)-naphthalene-1-sulfonyl (Dns)-Pro-Lys-Arg-Ala-Pro-
Trp-Val [27]. Assays were performed in 0.1 M Tris^HCl bu¡er pH
8.0 in a total volume of 400 Wl (excitation at 280 nm, emission at
350 nm).
The kinetic parameters kcat, Km and kcat/Km were calculated by
directly ¢tting the data to the Michaelis^Menten equation using Gra-
Fit 4.0 (Erithacus Software Ltd., Staines, UK).
3. Results
3.1. Site speci¢c mutagenesis and bacterial protein expression
Two mutants were created, based on the plasmid pET3a-
astacin [24], containing the cDNA of the mature astacin fused
with a C-terminal tag of ¢ve histidine residues (His-tag) to be
used for subsequent a⁄nity puri¢cation. In order to investi-
gate the function of Glu93 and Tyr149, both residues were
replaced by a PCR-based mutagenesis by alanine and phenyl-
alanine, respectively. The resulting circular plasmids contain-
ing the point mutations were veri¢ed by sequencing and used
to transform E. coli BL21(DE3) cells (not shown). Protein
expression was induced after the cells were grown to an opti-
cal density of A600nm = 0.7^0.9 by addition of 0.4 mM IPTG,
leading to the formation of inclusion bodies containing the
proteins of interest.
3.2. Protein puri¢cation and renaturation
As the overexpressed proteins were deposited in the form of
inclusion bodies in the cytoplasm, they had to be solubilized
using GuHCl and L-mercaptoethanol. The whole bacterial cell
extract was then submitted to a Ni-NTA a⁄nity chromatog-
raphy. Like recombinant wild-type astacin, the astacin var-
iants were eluted in a single peak at pH 4.5. The pooled
fractions were renatured in the presence of Pro-Leu-Gly-
NHOH (a competitive inhibitor of astacin) before applying
them to a Pro-Leu-Gly-NHOH a⁄nity column [24]. Under
these conditions, only enzyme molecules with a correctly
folded active site bind to the column [14,24]. Each of the
selectively separated renatured astacin variants was collected
in a single peak, respectively, which was resolved as a distinct
band in SDS^PAGE and Western blot analysis (Fig. 2). The
recombinant astacins have a higher molecular mass (Mr
23 581) compared to the cray¢sh enzyme (Mr 22 614), due to
the His-tag. Recombinant wild-type astacin treated in the
same way as the mutants was used as a standard.
3.3. Enzyme activity
Gelatin zymography was used to qualitatively analyze the
proteolytic activity of the astacin variants. After Pro-Leu-Gly-
NHOH a⁄nity chromatography, recombinant Y149F-astacin,
but not E93A-astacin, shows proteolytic degradation of gela-
tin (Fig. 3). Compared to the recombinant wild-type enzyme,
the Y149F-astacin proved to be less active. All three variants
were loaded at identical concentrations.
Fig. 2. Coomassie brilliant blue-stained 14% SDS^PAGE gel (A)
and Western blot analysis (B) of Y149F-astacin (3 Wg) and E93A-
astacin (1.3 Wg). Recombinant wild-type (WT) astacin (2 Wg) is
shown in comparison to the mutants. Cray¢sh astacin (5 Wg) is used
as a standard. The higher molecular weight of the recombinant asta-
cins is due to their His-tag. Polyclonal anti-astacin antiserum was
used for immunodetection.
Fig. 3. Proteolytic activity of the recombinant astacin variants is
shown by digestion of immobilized gelatin (0.1%) in a 14% SDS^
PAGE gel, stained with Coomassie brilliant blue. Y149F-astacin
(20 ng) is less active compared to recombinant wild-type (WT) asta-
cin (20 ng). No activity is detectable for E93A-astacin (20 ng).
Cray¢sh astacin is shown as a standard (left lane 10 ng, right lane
5 ng).
Fig. 4. The Michaelis^Menten diagram shows the hydrolysis of
Dns-PKRAPWV by 1U1037 M Y149F-astacin (in 0.1 M Tris^HCl
bu¡er pH 8.0 at 25‡C). The kinetic parameters for cleavage of the
£uorescent substrate are calculated with Km = 1.2U1034 M,
kcat = 0.54 s31 and kcat/Km = 4.5U1033 M31 s31.
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3.4. Enzyme kinetics
To quantify the enzymatic activity of the astacin mutants
and to analyze the in£uence of substituting the residues Glu93
and Tyr149 on substrate binding and catalysis, a £uorimetric
assay was carried out. Determination of the kinetic parame-
ters Km, kcat and kcat/Km was performed for the hydrolysis of
the £uorescent substrate Dns-Pro-Lys-Arg-Ala-Pro-Trp-Val
by wild-type and mutant astacins. This peptide is one of the
most sensitive substrates known for astacin [27]. Compared to
recombinant wild-type astacin, the Y149F mutant shows a 40-
fold drop of the kcat/Km value (from 1.8U105 M31 s31 to
4.5U103 M31 s31, respectively), while E93A-astacin proved
to be inactive (Fig. 4, Table 1). The reduced activity of
Y149F-astacin is mainly due to a decrease of kcat, and the
corresponding Km (1.2U1034 M) is only about one third of
the value determined for the recombinant wild-type enzyme
(Km = 3.2U1034 M).
4. Discussion
In the proposed mechanism of substrate hydrolysis by the
zinc endopeptidase astacin, Glu93 was suggested previously to
act as the general base, responsible for the polarization of the
catalytic water molecule and proton transfer from this water
molecule to the amide group of the scissile peptide bond [16].
It has been proposed also that the zinc ligand Tyr149 assists
in catalysis by stabilizing the transition state during peptide
hydrolysis.
To prove this hypothesis, site-directed mutagenesis was
used to substitute two key residues in the active center of
astacin by non-functional ones. The mutants Tyr149Phe-asta-
cin and Glu93Ala-astacin were expressed, puri¢ed and folded.
As recently described [24], Pro-Leu-Gly-NHOH a⁄nity
chromatography is an e¡ective method to discriminate be-
tween correctly folded astacin molecules and unfolded forms.
The hydroxamate Pro-Leu-Gly-NHOH is a competitive inhib-
itor of astacin [16]. It complexes the zinc ion in the catalytic
center and aligns in an antiparallel manner along the so-called
edge strand forming the rim of the active site cleft. Both
mutants bind to this column in the same manner as the
wild-type protein, a strong indication for their native-like
fold. It has been shown also that amino-terminally extended
proforms of the astacin-like proteases like human promeprin
only bind to Pro-Leu-Gly-NHOH after removal of the pro-
peptide [14]. This is further evidence that binding to this in-
hibitor is a good indication for a correct conformation and
accessibility of the active site.
The consequence of replacing the residues Glu93 and
Tyr149 was demonstrated in activity assays. The Glu93Ala
mutant is inactive in both, gelatin zymography and toward
the £uorescent substrate Dns-Pro-Lys-Arg*Ala-Pro-Trp-Val,
the best astacin substrate known so far [27]. This supports
the essential role of Glu93 as the general base during catalysis.
Interestingly, the substitution of the critical Glu198 residue in
matrilysin resulted in an enzyme species displaying still resid-
ual activity albeit about 2000-fold less than the wild-type pro-
tease [28]. In these experiments, the Glu198Ala mutant of
matrilysin was assayed at a 42-fold higher concentration as
the wild-type enzyme [28]. For comparison, in the case of
astacin, the concentration of the Glu93Ala mutant used for
activity assays was 350-fold higher than the wild-type stan-
dard. Even under these conditions there was no activity de-
tectable.
The Tyr149Phe mutant retains a reduced activity, which is
mainly due to an about 100-fold decrease of kcat. The decrease
to about one third of the Km value of the mutant compared to
the recombinant wild-type enzyme is probably due to the
lacking hydroxyl group of the substituted residue and hence
to the missing ability to provide a hydrogen bond. The activ-
ity of the Tyr149Phe mutant indicates that Tyr149 is not in-
dispensable for catalysis. But its importance for catalysis is
shown by the fact that its presence enhances catalysis about
40-fold (kcat/Km). Therefore Tyr149 is probably responsible
for the stabilization of the transition state during substrate
hydrolysis, as previously proposed by [16]. The position of
Tyr149 in the X-ray structure of astacin complexed with a
phosphinic transition state analogue is in agreement with
this function. Hence, the tyrosine switch mechanism implies
the opening of a gap between the tyrosine phenolic group and
the zinc ion into which the inhibitor’s phosphinyl group is
inserted. The distance of 0.27 nm between the hydroxyl group
of Tyr149 and one lower oxygen of the phosphinyl group’s
oxygen atoms (mimicking the transition state of the scissile
peptide bond) enables the formation of a hydrogen bond [16].
The participation of Tyr149 in substrate binding is also indi-
cated by the Cu(II)-astacin absorption spectrum. As shown
previously, the spectrum of free Cu(II)-astacin shows two in-
tense absorption maxima at 445 nm and 325 nm, indicative of
oxygen^metal charge transfer between the tyrosine phenol
group and the metal [29]. Upon addition of the phosphona-
midate inhibitor Z-F8(PO2NH)APF to Cu(II)-astacin, we ob-
served a decrease of both of these spectral maxima (unpub-
lished results), indicating that the interaction of the phenolic
oxygen with the metal ion in the catalytic center is inter-
rupted. The same result was reported recently for copper as-
tacin from Procambarus spp. [30].
The data presented here strongly support the hypothesis
that Tyr149 of astacin is involved in substrate binding and
in stabilization of the transition state during catalysis, while
the role of the general base is played by Glu93.
Acknowledgements: This work was supported by the Deutsche For-
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Table 1
Kinetic analysis of recombinant wild-type astacin and astacin mutants
Astacin variant (M) Km (M) kcat (s31) kcat/Km (M31 s31) Substrate (M)
Wild-type astacin (1U1039) 3.2U1034 57.86 1.81U105 5U1036^1U1033
Y149F-astacin (1U1037) 1.2U1034 0.54 4.5U103 2U1036^6U1034
E93A-astacin (3.5U1037) no detectable activity 5U1034^1U1033
The enzyme concentrations and the substrate ranges used in the assays are indicated. The enzymatic substrate cleavage was monitored at 25‡C
in 0.1 M Tris^HCl bu¡er pH 8.0. Based on the kcat/Km value for recombinant wild-type astacin, the Y149F-astacin retains an activity of about
2.5%. For E93A-astacin no activity was detectable.
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